Michelle A Fortier1, Winnie W Chung2, Ariana Martinez3, Sergio Gago-Masague4, Leonard Sender5. 1. Department of Anesthesiology & Perioperative Care, University of California-Irvine, 505 S. Main St., Suite 940, Orange, CA 92868, USA; Department of Pediatric Psychology, CHOC Children's Hospital, 1201 W. La Veta Avenue, Orange, CA 92868, USA; UCI Center on Stress & Health, School of Medicine, University of California-Irvine, 505 S. Main St., Suite 940, Orange, CA 92868, USA. Electronic address: mfortier@uci.edu. 2. Department of Pediatric Psychology, CHOC Children's Hospital, 1201 W. La Veta Avenue, Orange, CA 92868, USA. 3. Department of Anesthesiology & Perioperative Care, University of California-Irvine, 505 S. Main St., Suite 940, Orange, CA 92868, USA; UCI Center on Stress & Health, School of Medicine, University of California-Irvine, 505 S. Main St., Suite 940, Orange, CA 92868, USA. 4. California Institute of Telecommunications and Information Technology (Calit2), University of California-Irvine, Calit2 Administration, 4100 Calit2 Building, Irvine, CA 92697-2800, USA. 5. Chao Family Comprehensive Cancer Center, University of California-Irvine, Building 23, 101 The City Drive South, Orange, CA 92868, USA.
Abstract
BACKGROUND: Over 12,000 children are diagnosed with cancer every year in the United States. In addition to symptoms associated with their disease, children undergoing chemotherapy frequently experience significant pain, which is unfortunately often undertreated. The field of m-Health offers an innovative avenue for pain assessment and intervention in the home setting. The current study describes the development and initial evaluation of a tablet-based program, Pain Buddy, aimed to enhance pain management and foster improved quality of life in children ages 8-18 years undergoing cancer treatment. METHODS: An animated avatar-based tablet application was developed using state-of-the-art software. Key aspects of Pain Buddy include daily pain and symptom diaries completed by children, remote monitoring of symptoms by uploading patient's data through internet to a cloud server, cognitive and behavioral skills training, interactive three-dimensional avatars that guide children through the program, and an incentive system to motivate engagement. Twelve children between the ages of 8 and 18 participated in a pilot study of Pain Buddy. RESULTS: Children were highly satisfied with the program. Pain and appetite disturbances were most frequently endorsed. Symptom trigger alerts to outside providers were largely related to clinically significant pain. Children infrequently used analgesics, and reported using some non-pharmacological pain management strategies. CONCLUSION: Pain Buddy appears to be a promising tool to improve pain and symptom management in children undergoing cancer treatment. Results from the current study will inform future improvements to Pain Buddy, in preparation for a randomized controlled trial to assess the efficacy of this innovative treatment.
BACKGROUND: Over 12,000 children are diagnosed with cancer every year in the United States. In addition to symptoms associated with their disease, children undergoing chemotherapy frequently experience significant pain, which is unfortunately often undertreated. The field of m-Health offers an innovative avenue for pain assessment and intervention in the home setting. The current study describes the development and initial evaluation of a tablet-based program, Pain Buddy, aimed to enhance pain management and foster improved quality of life in children ages 8-18 years undergoing cancer treatment. METHODS: An animated avatar-based tablet application was developed using state-of-the-art software. Key aspects of Pain Buddy include daily pain and symptom diaries completed by children, remote monitoring of symptoms by uploading patient's data through internet to a cloud server, cognitive and behavioral skills training, interactive three-dimensional avatars that guide children through the program, and an incentive system to motivate engagement. Twelve children between the ages of 8 and 18 participated in a pilot study of Pain Buddy. RESULTS:Children were highly satisfied with the program. Pain and appetite disturbances were most frequently endorsed. Symptom trigger alerts to outside providers were largely related to clinically significant pain. Children infrequently used analgesics, and reported using some non-pharmacological pain management strategies. CONCLUSION:Pain Buddy appears to be a promising tool to improve pain and symptom management in children undergoing cancer treatment. Results from the current study will inform future improvements to Pain Buddy, in preparation for a randomized controlled trial to assess the efficacy of this innovative treatment.
Authors: Michelle A Fortier; Aditi Wahi; Colette Bruce; Eva L Maurer; Robert Stevenson Journal: Pediatr Blood Cancer Date: 2013-12-24 Impact factor: 3.167
Authors: Ashley N Junghans-Rutelonis; Karen E Weiss; Mary Anne Tamula; Dina Karvounides; Cindy Harbeck-Weber; Staci Martin Journal: Prof Psychol Res Pr Date: 2017-12
Authors: Michelle A Fortier; Sun Yang; Michael T Phan; Daniel M Tomaszewski; Brooke N Jenkins; Zeev N Kain Journal: Pediatr Blood Cancer Date: 2019-12-18 Impact factor: 3.167
Authors: Patricia A Richardson; Lauren E Harrison; Lauren C Heathcote; Gillian Rush; Deborah Shear; Chitra Lalloo; Korey Hood; Rikard K Wicksell; Jennifer Stinson; Laura E Simons Journal: Expert Rev Neurother Date: 2020-09-23 Impact factor: 4.618
Authors: Jacqueline Vaughn; Donruedee Kamkhoad; Ryan J Shaw; Sharron L Docherty; Arvind P Subramaniam; Nirmish Shah Journal: J Am Med Inform Assoc Date: 2021-07-14 Impact factor: 4.497
Authors: Lauri A Linder; Amy R Newman; Kristin Stegenga; Yin-Shun Chiu; Sarah E Wawrzynski; Heidi Kramer; Charlene Weir; Scott Narus; Roger Altizer Journal: Support Care Cancer Date: 2020-05-02 Impact factor: 3.603